ARG70636

Hantaan Virus nucleocapsid peptide

Hantaan Virus nucleocapsid peptide for Blocking

Overview

Product Description The peptide is used for blocking the activity of anti-Hantaan Virus nucleocapsid antibody ARG46772
Tested Application BL
Target Name Hantaan Virus nucleocapsid
A.A. Sequence 18 amino acids near the amino terminus of the Hantaan virus nucleocapsid.

Application Instructions

Application Suggestion
Tested Application Dilution
BLAssay-dependent
Application Note This peptide usually blocks anti-Hantaan Virus nucleocapsid antibody ARG46772
activity completely by incubating the peptide with equal volume of antibody for 30 min at at 37°C.

Properties

Form Liquid
Buffer PBS (pH 7.2), 0.02% sodium azide and 0.1% BSA
Concentration 200 µg/ml
Storage Instruction Store peptide at -20°C, stable for one year. After reconstitution, aliquot and store at -20°C or -80°C for up to one month. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Background Hantaan virus (HNTV) is the prototype virus of the genus hantavirus of the family Bunyaviridae, an enveloped, negative-sense RNA virus that is the eiological agent of Korean hemorrhagic fever (1). Infection of cultured Vero E6 cells with HNTV induced expression of the heat shock protein HSP70. A substantial fraction of HSP70 was found to be associated with the HNTV nucleocapsid (NP) (2). Vero E6 cells that overexpress HSP70 show significantly reduced levels of NP and an increased resistance to infection by HNTV (2).